Shp2 Blockade Enhances Anti-tumor Immunity Through Tumor Cell Intrinsic And Extrinsic Mechanisms
Vasant Narasimhan, 41, chief healthcare officer and worldwide head of drug development at Novartis will take over as the CEO of Europe’s largest drugmaker immediately after the company announced the surprise departure of CEO Joseph Jimenez after eight years at the helm. Narsimhan, a Harvard-educated medical professional will succeed Jimenez...